MENU
CMPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more

A.I. Advisor
published Earnings

CMPX is expected to report earnings to rise 28.38% to -10 cents per share on February 27

Compass Therapeutics CMPX Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.06
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
The last earnings report on November 05 showed earnings per share of -7 cents, beating the estimate of -14 cents. With 1.72M shares outstanding, the current market capitalization sits at 848.40M.
View a ticker or compare two or three
CMPX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CMPX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com